Original Article
Copyright ©2010 Baishideng.
World J Hepatol. Jan 27, 2010; 2(1): 32-41
Published online Jan 27, 2010. doi: 10.4254/wjh.v2.i1.32
Table 1 Clinical and laboratory data of all studied cases (mean ± SD) n(%)
ParametersControlCHC without cirrhosisCHC with cirrhosisHCV-related HCC
(n = 15)(n = 50)(n = 30)(n = 30)
Age45.0 ± 7.547.4 ± 9.351.3 ± 5.948.9 ± 7.2
Male/female ratio2/17/32/12/1
Pallor0 (0)2 (4.0)5 (16.5)8 (26.6)
Jaundice0 (0)3 (6.0)6 (20.0)13 (43.3)
Palmer erythema0 (0)0 (0)15 (50.0)17 (56.6)
Spider naevi0 (0)0 (0)13 (43.3)16 (53.3)
Lower limb edema0 (0)0 (0)16 (53.3)10(33.3)
Child classification
A0 (0)50 (100)8 (26.6)1 (3.3)
B0 (0)9 (30.0)11 (36.6)
C0 (0)13 (43.3)18 (60.0)
ALT (IU/L)32.6 ± 4.263.2 ± 29.751.8 ± 4.378.1 ± 16.3
AST (IU/L)31.1 ± 5.149.1 ± 18.346.4 ± 5.168.3 ± 12.4
Albumin (g/dL)4.4 ± 0.53.80 ± 0.32.90 ± 0.72.80 ± 0.4
PT conc.97.6 ± 3.489.7 ± 5.853.4 ± 11.268.5 ± 3.8